CGNH
Cardiogenics Holdings Inc. (CGNH)
Market Open
6 Aug, 13:31
OTC PINK OTC PINK Primary $
0. 00
0
0%
$
12.02K Market Cap
- P/E Ratio
0% Div Yield
0 Volume
0 Eps
$ 0
Previous Close Day Range
0 0
Year Range
0 0
Want to track CGNH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
CGNH trading today higher at $0, an increase of 0% from yesterday's close, completing a monthly increase of 0% or $0. Over the past 12 months, CGNH stock gained 0%.
CGNH is not paying dividends to its shareholders.
The last earnings report, released on Jan 31, 2016, missed the consensus estimates by 0%. On average, the company has fell short of earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).
CGNH Chart
Cardiogenics Holdings Inc. Dividends
CGNH is not paying dividends to its shareholders.
Cardiogenics Holdings Inc. Earnings
| 31 Jan 2016 Date | | - Cons. EPS | - EPS |
| 31 Oct 2015 Date | | - Cons. EPS | - EPS |
| 31 Jul 2015 Date | | - Cons. EPS | - EPS |
| 30 Apr 2015 Date | | - Cons. EPS | 0 EPS |
| 31 Jan 2015 Date | | - Cons. EPS | - EPS |
CGNH is not paying dividends to its shareholders.
| 31 Jan 2016 Date | | - Cons. EPS | - EPS |
| 31 Oct 2015 Date | | - Cons. EPS | - EPS |
| 31 Jul 2015 Date | | - Cons. EPS | - EPS |
| 30 Apr 2015 Date | | - Cons. EPS | 0 EPS |
| 31 Jan 2015 Date | | - Cons. EPS | - EPS |
Cardiogenics Holdings Inc. (CGNH) FAQ
What is the stock price today?
The current price is $0.00.
On which exchange is it traded?
Cardiogenics Holdings Inc. is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is CGNH.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0%.
What is its market cap?
As of today, the market cap is 12.02K.
Has Cardiogenics Holdings Inc. ever had a stock split?
No, there has never been a stock split.
Cardiogenics Holdings Inc. Profile
| Medical - Diagnostics & Research Industry | Healthcare Sector | Dr. Yahia Abdul Gawad Ch.B., M.D., MB, MSc. CEO | OTC PINK Exchange | US14160X2036 ISIN |
| CA Country | 4 Employees | - Last Dividend | 22 Jun 2010 Last Split | - IPO Date |
Overview
CardioGenics Holdings Inc. specializes in the development and commercialization of innovative diagnostic test products aimed at the in vitro diagnostics testing market globally, including regions such as the United States, Canada, Europe, and beyond. The company has transitioned from its former identity, Jag Media Holdings, Inc., to CardioGenics Holdings Inc. in 2009, signifying a pointed shift towards its current focus on cardiovascular diagnostics. Established in 1997 and headquartered in Mississauga, Canada, CardioGenics has carved a niche in addressing pressing demands for immediate, reliable, and convenient diagnostic solutions for cardiac health management.
Products and Services
CardioGenics Holdings Inc. offers a focused portfolio of diagnostic products and technologies designed to enhance the efficiency and accuracy of cardiac health diagnostics at the point of care and within laboratory settings. These include:
- QL Care Analyzer: This innovative product stands out as a compact, standalone, and automated point-of-care (POC) immunoassay analyzer. It is known for its unique feature of utilizing a proprietary self-metering cartridge, enabling it to conduct immunoassay tests directly at the care point without necessitating extensive lab equipment. The QL Care Analyzer is tailored for rapid deployment and use in various healthcare settings, enabling timely decision-making in critical care situations.
- Immunoassay Tests for Cardiac Markers: CardioGenics has developed a series of immunoassay tests specifically designed to detect cardiac markers present in the blood during a heart attack. These tests are crucial for the swift identification of cardiac events, allowing healthcare providers to administer appropriate treatments in a timely manner, potentially saving lives and reducing the likelihood of long-term cardiac damage.
- Paramagnetic Beads: As part of its offerings to clinical and research laboratories, CardioGenics provides paramagnetic beads. These beads serve as solid surfaces in the performance of heterogeneous immunoassay tests. Their application significantly enhances the precision and reliability of immunoassay procedures, thereby supporting various research and diagnostic activities that require high levels of assay sensitivity and specificity.
Contact Information
Address: 6295 Northam Drive
Phone: 905-673-8501
Website: https://www.cardiogenics.com
2025 © Marketlog. All Rights Reserved.
